Chemotherapy-induced peripheral neuropathy (CIPN ... and exploring effective treatment options. One promising area of research involves the use of neurofilament light chain (NFL) as a biomarker ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

BC, CNM, RNFA, spoke about the oncology nurse’s and APP’s roles in managing chemotherapy-induced peripheral neuropathy in ...

Long-term use of these cholesterol-lowering drugs can cause peripheral neuropathy. Amiodarone. This drug, used for arrhythmias, may cause peripheral neuropathy. Chemotherapy drugs. Some chemo ...

An APP’s research is focused on chemo-induced peripheral neuropathy in Black breast cancer survivors and its impact on their long-term quality of life. Given the significant number of breast cancer ...

including chemotherapy-induced peripheral neuropathy, diabetic neuropathy, cancer bone pain, and osteoarthritis. Based on the safety profile of ART26.12 in preclinical studies, the company looks ...

Peripheral neuropathy ... one through treatment, remember that you do not have to walk this road alone. Ask your doctor about all available treatment options, including the possibility of ...